世界の経口免疫賦活剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Oral Immunostimulant Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5914
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、経口免疫賦活剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インターロイキン、グルカン、リポ多糖、レバミゾール、イソプリノシン）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・経口免疫賦活剤の市場動向
・企業の競争状況、市場シェア
・経口免疫賦活剤の種類別市場規模と予測2016-2027（インターロイキン、グルカン、リポ多糖、レバミゾール、イソプリノシン）
・経口免疫賦活剤の用途別市場規模と予測2016-2027（病院薬局、小売薬局、ドラッグストア、オンライン薬局）
・経口免疫賦活剤の北米市場規模2016-2027（アメリカ、カナダ）
・経口免疫賦活剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・経口免疫賦活剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・経口免疫賦活剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・経口免疫賦活剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Step-Pharma、Novartis、Abbott、Amgen、Biogen、Johnson & Johnson、Merck & Co.、Eli Lilly and Company、Hoffmann-La Roche）
・結論

Market Analysis and Insights: Global Oral Immunostimulant Market
The global Oral Immunostimulant market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Immunostimulant market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Immunostimulant market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Immunostimulant market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Immunostimulant market.

Global Oral Immunostimulant Scope and Market Size
Oral Immunostimulant market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Immunostimulant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Interleukins
Glucan
Lipopolysaccharides
Levamisole
Isoprinosine

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Step-Pharma
Novartis
Abbott
Amgen
Biogen
Johnson & Johnson
Merck & Co.
Eli Lilly and Company
Hoffmann-La Roche

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Immunostimulant Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Interleukins
1.2.3 Glucan
1.2.4 Lipopolysaccharides
1.2.5 Levamisole
1.2.6 Isoprinosine
1.3 Market by Application
1.3.1 Global Oral Immunostimulant Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oral Immunostimulant Market Perspective (2016-2027)
2.2 Oral Immunostimulant Growth Trends by Regions
2.2.1 Oral Immunostimulant Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Immunostimulant Historic Market Share by Regions (2016-2021)
2.2.3 Oral Immunostimulant Forecasted Market Size by Regions (2022-2027)
2.3 Oral Immunostimulant Industry Dynamic
2.3.1 Oral Immunostimulant Market Trends
2.3.2 Oral Immunostimulant Market Drivers
2.3.3 Oral Immunostimulant Market Challenges
2.3.4 Oral Immunostimulant Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oral Immunostimulant Players by Revenue
3.1.1 Global Top Oral Immunostimulant Players by Revenue (2016-2021)
3.1.2 Global Oral Immunostimulant Revenue Market Share by Players (2016-2021)
3.2 Global Oral Immunostimulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Immunostimulant Revenue
3.4 Global Oral Immunostimulant Market Concentration Ratio
3.4.1 Global Oral Immunostimulant Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Immunostimulant Revenue in 2020
3.5 Oral Immunostimulant Key Players Head office and Area Served
3.6 Key Players Oral Immunostimulant Product Solution and Service
3.7 Date of Enter into Oral Immunostimulant Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Immunostimulant Breakdown Data by Type
4.1 Global Oral Immunostimulant Historic Market Size by Type (2016-2021)
4.2 Global Oral Immunostimulant Forecasted Market Size by Type (2022-2027)

5 Oral Immunostimulant Breakdown Data by Application
5.1 Global Oral Immunostimulant Historic Market Size by Application (2016-2021)
5.2 Global Oral Immunostimulant Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oral Immunostimulant Market Size (2016-2027)
6.2 North America Oral Immunostimulant Market Size by Type
6.2.1 North America Oral Immunostimulant Market Size by Type (2016-2021)
6.2.2 North America Oral Immunostimulant Market Size by Type (2022-2027)
6.2.3 North America Oral Immunostimulant Market Size by Type (2016-2027)
6.3 North America Oral Immunostimulant Market Size by Application
6.3.1 North America Oral Immunostimulant Market Size by Application (2016-2021)
6.3.2 North America Oral Immunostimulant Market Size by Application (2022-2027)
6.3.3 North America Oral Immunostimulant Market Size by Application (2016-2027)
6.4 North America Oral Immunostimulant Market Size by Country
6.4.1 North America Oral Immunostimulant Market Size by Country (2016-2021)
6.4.2 North America Oral Immunostimulant Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Oral Immunostimulant Market Size (2016-2027)
7.2 Europe Oral Immunostimulant Market Size by Type
7.2.1 Europe Oral Immunostimulant Market Size by Type (2016-2021)
7.2.2 Europe Oral Immunostimulant Market Size by Type (2022-2027)
7.2.3 Europe Oral Immunostimulant Market Size by Type (2016-2027)
7.3 Europe Oral Immunostimulant Market Size by Application
7.3.1 Europe Oral Immunostimulant Market Size by Application (2016-2021)
7.3.2 Europe Oral Immunostimulant Market Size by Application (2022-2027)
7.3.3 Europe Oral Immunostimulant Market Size by Application (2016-2027)
7.4 Europe Oral Immunostimulant Market Size by Country
7.4.1 Europe Oral Immunostimulant Market Size by Country (2016-2021)
7.4.2 Europe Oral Immunostimulant Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oral Immunostimulant Market Size (2016-2027)
8.2 Asia-Pacific Oral Immunostimulant Market Size by Type
8.2.1 Asia-Pacific Oral Immunostimulant Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Immunostimulant Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Immunostimulant Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Immunostimulant Market Size by Application
8.3.1 Asia-Pacific Oral Immunostimulant Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Immunostimulant Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Immunostimulant Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Immunostimulant Market Size by Region
8.4.1 Asia-Pacific Oral Immunostimulant Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Immunostimulant Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oral Immunostimulant Market Size (2016-2027)
9.2 Latin America Oral Immunostimulant Market Size by Type
9.2.1 Latin America Oral Immunostimulant Market Size by Type (2016-2021)
9.2.2 Latin America Oral Immunostimulant Market Size by Type (2022-2027)
9.2.3 Latin America Oral Immunostimulant Market Size by Type (2016-2027)
9.3 Latin America Oral Immunostimulant Market Size by Application
9.3.1 Latin America Oral Immunostimulant Market Size by Application (2016-2021)
9.3.2 Latin America Oral Immunostimulant Market Size by Application (2022-2027)
9.3.3 Latin America Oral Immunostimulant Market Size by Application (2016-2027)
9.4 Latin America Oral Immunostimulant Market Size by Country
9.4.1 Latin America Oral Immunostimulant Market Size by Country (2016-2021)
9.4.2 Latin America Oral Immunostimulant Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oral Immunostimulant Market Size (2016-2027)
10.2 Middle East & Africa Oral Immunostimulant Market Size by Type
10.2.1 Middle East & Africa Oral Immunostimulant Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Immunostimulant Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Immunostimulant Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Immunostimulant Market Size by Application
10.3.1 Middle East & Africa Oral Immunostimulant Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Immunostimulant Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Immunostimulant Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Immunostimulant Market Size by Country
10.4.1 Middle East & Africa Oral Immunostimulant Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Immunostimulant Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Oral Immunostimulant Introduction
11.1.4 Pfizer Revenue in Oral Immunostimulant Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Step-Pharma
11.2.1 Step-Pharma Company Details
11.2.2 Step-Pharma Business Overview
11.2.3 Step-Pharma Oral Immunostimulant Introduction
11.2.4 Step-Pharma Revenue in Oral Immunostimulant Business (2016-2021)
11.2.5 Step-Pharma Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Oral Immunostimulant Introduction
11.3.4 Novartis Revenue in Oral Immunostimulant Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Oral Immunostimulant Introduction
11.4.4 Abbott Revenue in Oral Immunostimulant Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Oral Immunostimulant Introduction
11.5.4 Amgen Revenue in Oral Immunostimulant Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Biogen
11.6.1 Biogen Company Details
11.6.2 Biogen Business Overview
11.6.3 Biogen Oral Immunostimulant Introduction
11.6.4 Biogen Revenue in Oral Immunostimulant Business (2016-2021)
11.6.5 Biogen Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Oral Immunostimulant Introduction
11.7.4 Johnson & Johnson Revenue in Oral Immunostimulant Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Details
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Oral Immunostimulant Introduction
11.8.4 Merck & Co. Revenue in Oral Immunostimulant Business (2016-2021)
11.8.5 Merck & Co. Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Oral Immunostimulant Introduction
11.9.4 Eli Lilly and Company Revenue in Oral Immunostimulant Business (2016-2021)
11.9.5 Eli Lilly and Company Recent Development
11.10 Hoffmann-La Roche
11.10.1 Hoffmann-La Roche Company Details
11.10.2 Hoffmann-La Roche Business Overview
11.10.3 Hoffmann-La Roche Oral Immunostimulant Introduction
11.10.4 Hoffmann-La Roche Revenue in Oral Immunostimulant Business (2016-2021)
11.10.5 Hoffmann-La Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oral Immunostimulant Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Interleukins
Table 3. Key Players of Glucan
Table 4. Key Players of Lipopolysaccharides
Table 5. Key Players of Levamisole
Table 6. Key Players of Isoprinosine
Table 7. Global Oral Immunostimulant Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Oral Immunostimulant Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Oral Immunostimulant Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Oral Immunostimulant Market Share by Regions (2016-2021)
Table 11. Global Oral Immunostimulant Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Oral Immunostimulant Market Share by Regions (2022-2027)
Table 13. Oral Immunostimulant Market Trends
Table 14. Oral Immunostimulant Market Drivers
Table 15. Oral Immunostimulant Market Challenges
Table 16. Oral Immunostimulant Market Restraints
Table 17. Global Oral Immunostimulant Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Oral Immunostimulant Market Share by Players (2016-2021)
Table 19. Global Top Oral Immunostimulant Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Immunostimulant as of 2020)
Table 20. Ranking of Global Top Oral Immunostimulant Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Oral Immunostimulant Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oral Immunostimulant Product Solution and Service
Table 24. Date of Enter into Oral Immunostimulant Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Immunostimulant Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Oral Immunostimulant Revenue Market Share by Type (2016-2021)
Table 28. Global Oral Immunostimulant Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Oral Immunostimulant Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Oral Immunostimulant Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Oral Immunostimulant Revenue Market Share by Application (2016-2021)
Table 32. Global Oral Immunostimulant Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Oral Immunostimulant Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Oral Immunostimulant Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Oral Immunostimulant Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Oral Immunostimulant Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Oral Immunostimulant Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Oral Immunostimulant Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Oral Immunostimulant Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Oral Immunostimulant Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Oral Immunostimulant Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Oral Immunostimulant Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Oral Immunostimulant Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Oral Immunostimulant Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Oral Immunostimulant Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oral Immunostimulant Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oral Immunostimulant Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oral Immunostimulant Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Oral Immunostimulant Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Oral Immunostimulant Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Oral Immunostimulant Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Oral Immunostimulant Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Oral Immunostimulant Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Oral Immunostimulant Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Oral Immunostimulant Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Oral Immunostimulant Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Oral Immunostimulant Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oral Immunostimulant Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oral Immunostimulant Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oral Immunostimulant Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Oral Immunostimulant Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Oral Immunostimulant Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Oral Immunostimulant Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Oral Immunostimulant Product
Table 67. Pfizer Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Step-Pharma Company Details
Table 70. Step-Pharma Business Overview
Table 71. Step-Pharma Oral Immunostimulant Product
Table 72. Step-Pharma Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 73. Step-Pharma Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Oral Immunostimulant Product
Table 77. Novartis Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Oral Immunostimulant Product
Table 82. Abbott Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 83. Abbott Recent Development
Table 84. Amgen Company Details
Table 85. Amgen Business Overview
Table 86. Amgen Oral Immunostimulant Product
Table 87. Amgen Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 88. Amgen Recent Development
Table 89. Biogen Company Details
Table 90. Biogen Business Overview
Table 91. Biogen Oral Immunostimulant Product
Table 92. Biogen Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 93. Biogen Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Oral Immunostimulant Product
Table 97. Johnson & Johnson Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 98. Johnson & Johnson Recent Development
Table 99. Merck & Co. Company Details
Table 100. Merck & Co. Business Overview
Table 101. Merck & Co. Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 102. Merck & Co. Recent Development
Table 103. Eli Lilly and Company Company Details
Table 104. Eli Lilly and Company Business Overview
Table 105. Eli Lilly and Company Oral Immunostimulant Product
Table 106. Eli Lilly and Company Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 107. Eli Lilly and Company Recent Development
Table 108. Hoffmann-La Roche Company Details
Table 109. Hoffmann-La Roche Business Overview
Table 110. Hoffmann-La Roche Oral Immunostimulant Product
Table 111. Hoffmann-La Roche Revenue in Oral Immunostimulant Business (2016-2021) & (US$ Million)
Table 112. Hoffmann-La Roche Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Immunostimulant Market Share by Type: 2020 VS 2027
Figure 2. Interleukins Features
Figure 3. Glucan Features
Figure 4. Lipopolysaccharides Features
Figure 5. Levamisole Features
Figure 6. Isoprinosine Features
Figure 7. Global Oral Immunostimulant Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Oral Immunostimulant Report Years Considered
Figure 13. Global Oral Immunostimulant Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Oral Immunostimulant Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Oral Immunostimulant Market Share by Regions: 2020 VS 2027
Figure 16. Global Oral Immunostimulant Market Share by Regions (2022-2027)
Figure 17. Global Oral Immunostimulant Market Share by Players in 2020
Figure 18. Global Top Oral Immunostimulant Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Immunostimulant as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Oral Immunostimulant Revenue in 2020
Figure 20. Global Oral Immunostimulant Revenue Market Share by Type (2016-2021)
Figure 21. Global Oral Immunostimulant Revenue Market Share by Type (2022-2027)
Figure 22. North America Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Oral Immunostimulant Market Share by Type (2016-2027)
Figure 24. North America Oral Immunostimulant Market Share by Application (2016-2027)
Figure 25. North America Oral Immunostimulant Market Share by Country (2016-2027)
Figure 26. United States Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Oral Immunostimulant Market Share by Type (2016-2027)
Figure 30. Europe Oral Immunostimulant Market Share by Application (2016-2027)
Figure 31. Europe Oral Immunostimulant Market Share by Country (2016-2027)
Figure 32. Germany Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Oral Immunostimulant Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Oral Immunostimulant Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Oral Immunostimulant Market Share by Region (2016-2027)
Figure 42. China Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Oral Immunostimulant Market Share by Type (2016-2027)
Figure 50. Latin America Oral Immunostimulant Market Share by Application (2016-2027)
Figure 51. Latin America Oral Immunostimulant Market Share by Country (2016-2027)
Figure 52. Mexico Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Oral Immunostimulant Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Oral Immunostimulant Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Oral Immunostimulant Market Share by Country (2016-2027)
Figure 58. Turkey Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Oral Immunostimulant Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 62. Step-Pharma Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 66. Biogen Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 68. Merck & Co. Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 69. Eli Lilly and Company Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 70. Hoffmann-La Roche Revenue Growth Rate in Oral Immunostimulant Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の経口抗糖尿病剤市場規模・現状・予測（2021年-2027年）

Global Oral Antidiabetic Agents Market Size, Status and Forecast 2021-2027
QFJ1-4620 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、経口抗糖尿病剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スルホニル尿素剤、メグリチニド、ビグアニド、チアゾリジンジオン、α-グルコシダーゼ阻害剤）、用途別市場規模（家庭用、医療機関、その他）、主...

世界の経口高分子製剤市場規模・現状・予測（2021年-2027年）

Global Oral Macromolecule Formulation Market Size, Status and Forecast 2021-2027
QFJ1-5915 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、経口高分子製剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、錠剤、液体）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のオーラルリンス市場規模・現状・予測（2021年-2027年）

Global Oral Rinse Market Size, Status and Forecast 2021-2027
QFJ1-4624 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、オーラルリンスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（防腐剤、鎮痛剤、抗真菌剤、抗炎症剤）、用途別市場規模（オンライン薬局、ドラッグストア、歯科医院、小売薬局）、主要地域別市場規模（北米、アメ...

世界の口腔ケア＆口腔衛生市場規模・現状・予測（2021年-2027年）

Global Oral Care and Oral Hygiene Market Size, Status and Forecast 2021-2027
QFJ1-4623 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、口腔ケア＆口腔衛生の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（歯磨き粉、歯ブラシ、うがい薬、歯科用アクセサリー、義歯製品、歯科補綴物洗浄剤）、用途別市場規模（消費者向け店舗、小売薬局、オンライン配...

世界の栄養補助食品用経口薄膜市場規模・現状・予測（2021年-2027年）

Global Nutraceutical Oral Thin Films Market Size, Status and Forecast 2021-2027
QFJ1-4600 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、栄養補助食品用経口薄膜の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酸化防止剤、多価不飽和脂肪酸、プレバイオティクス、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域...

世界の口腔がん診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4621 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、口腔がん診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コンピュータ断層撮影（CT）スキャン、磁気共鳴画像（MRI）、ポジトロン放出断層撮影（PET）、超音波検査、生検、X線、内視鏡検査、蛍光画像...

世界のIV＆経口鉄剤市場規模・現状・予測（2021年-2027年）

Global IV and Oral Iron Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5812 2021年6月 124Pages
QYResearch社発行の本調査レポートでは、IV＆経口鉄剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口鉄薬、IV鉄剤）、用途別市場規模（腎臓、OBGYN、手術、胃腸病、腫瘍、心不全（HF））、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の経口血糖降下薬市場規模・現状・予測（2021年-2027年）

Global Oral Hypoglycemic Agents Market Size, Status and Forecast 2021-2027
QFJ1-5913 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、経口血糖降下薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（液体、カプセル、錠剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の治療用タンパク質＆経口ワクチン市場規模・現状・予測（2021年-2027年）

Global Therapeutic Proteins and Oral Vaccines Market Size, Status and Forecast 2021-2027
QFJ1-6036 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、治療用タンパク質＆経口ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療用タンパク質、経口ワクチン）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ...

世界の調剤薬局市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Compounding Pharmacies Market The global Compounding Pharmacies market size is projected to reach US$ 13500 million by 2027, from US$ 11180 million in 2020, at a CAGR of 2.7% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, t…
世界の経口高分子製剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Macromolecule Formulation Market The global Oral Macromolecule Formulation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界のオーラルリンス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Rinse Market The global Oral Rinse market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant att…
世界の経口浸透圧性下剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Osmotic Laxative Market The global Oral Osmotic Laxative market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…
世界の栄養補助食品用経口薄膜市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nutraceutical Oral Thin Films Market The global Nutraceutical Oral Thin Films market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…